ARA-290 16MG is a specialised synthetic 11-amino-acid research peptide, also known as cibinetide, supplied by Axion Peptide Lab for controlled scientific, biochemical, and analytical investigation.
Suitable for qualified laboratory research involving peptide structure, molecular interactions, cellular signalling, and related experimental pathways.
For Research Use Only – Not for human consumption
$99.99
ARA-290 16MG is a specialised synthetic peptide material supplied for controlled scientific, biochemical, and analytical research. Also known as cibinetide, ARA290, or pyroglutamate helix B surface peptide, this molecule has attracted research interest because of its distinctive structure and its use in experimental investigations involving cellular signalling and tissue-protective pathways.
Axion Peptide Lab supplies ARA-290 16MG exclusively as a laboratory research material for qualified researchers, institutions, analytical facilities, and scientific organisations.
Each product should be handled according to appropriate laboratory procedures, with researchers reviewing available specifications and batch documentation before beginning experimental work.
For Research Use Only – Not for human consumption.
ARA-290, commonly referred to as cibinetide, is a synthetic peptide consisting of 11 amino acids. Its sequence is XEQLERALNSS, and the compound has a molecular formula of C51H84N16O21.
The molecule was developed as a small peptide designed to reproduce selected structural characteristics associated with the helix B region of erythropoietin while remaining structurally distinct from the complete erythropoietin molecule.
Its relatively compact peptide sequence makes ARA-290 an interesting material for scientists investigating relationships between molecular structure, receptor interactions, signalling pathways, cellular responses, and peptide stability.
Researchers may incorporate the material into carefully controlled experimental models according to their individual study objectives.
ARA-290 has become the subject of scientific investigation across several experimental fields.
A significant area of interest involves tissue-protective signalling and the molecular pathways associated with cellular responses to stress or injury. Researchers have also investigated the peptide in experimental models involving inflammatory signalling, cellular protection, neurological pathways, and related biochemical mechanisms.
These areas remain subjects of scientific investigation.
Results obtained from experimental models should not be interpreted as proof of therapeutic effectiveness or as recommendations for personal use. The material supplied by Axion Peptide Lab is a research compound rather than a medicine or consumer healthcare product.
Understanding how short peptide sequences interact with biological systems is an important component of modern biochemical research.
ARA-290 provides scientists with an opportunity to investigate a defined 11-amino-acid sequence within controlled experimental conditions.
Depending on the objectives of a particular study, researchers may examine characteristics including molecular interactions, receptor-associated activity, peptide stability, structure-function relationships, degradation patterns, biochemical responses, or concentration-dependent experimental observations.
Suitable analytical technologies and experimental controls should be selected by qualified researchers.
This makes careful experimental design particularly important when comparing ARA-290 with other peptide sequences or control materials.
ARA-290 16MG may also be useful within analytical laboratory workflows where researchers are studying peptide identity, molecular characteristics, stability, purity, or degradation.
Modern peptide analysis can involve a variety of laboratory techniques depending on the objective of the experiment.
Researchers should establish appropriate controls, equipment parameters, concentrations, sample preparation procedures, and analytical acceptance criteria before conducting an investigation.
Results should also be interpreted within the limitations of the experimental model being used.
Axion Peptide Lab does not provide personal dosing, administration, therapeutic, or clinical-use instructions for ARA-290.
Reliable scientific research requires appropriately characterised materials.
Unexpected impurities, contamination, incorrect identification, or inconsistent handling can introduce variables that make experimental results more difficult to interpret.
Researchers should therefore consider product identification, batch information, available analytical documentation, storage requirements, packaging integrity, and handling conditions when selecting peptide materials.
Axion Peptide Lab focuses on carefully sourced research materials supported by defined quality-control procedures.
Available documentation may vary between individual products and batches, so researchers should review product-specific information before beginning experimental work.
The 16MG format provides researchers with a clearly defined quantity for laboratory investigation.
This can be useful when planning controlled experimental workflows, comparative investigations, analytical testing, or repeated laboratory observations.
The appropriate quantity required for an experiment will depend entirely on the methodology established by the researcher.
The 16MG designation describes the amount of peptide material supplied and should not be interpreted as a recommended dose.
No information presented by Axion Peptide Lab is intended to provide instructions for administration to humans or animals.
Proper storage is an important consideration when working with research peptides.
Environmental conditions can influence peptide integrity over time. Temperature fluctuations, moisture, contamination, direct light, and inappropriate handling may affect experimental materials.
Researchers should therefore follow the product-specific storage information provided with their material and maintain appropriate laboratory records where required.
Research products should remain clearly labelled and separated from foods, medicines, supplements, and materials intended for personal consumption.
Only appropriately trained personnel should handle laboratory peptide materials.
Axion Peptide Lab specialises in research peptides, laboratory compounds, and related scientific materials intended for controlled research applications.
Our research-focused approach prioritises:
We aim to provide researchers with a dependable source of specialised laboratory materials while maintaining clear research-use restrictions throughout our catalogue.
Qualified customers can order ARA-290 16MG through Axion Peptide Lab for legitimate laboratory and analytical research.
Before purchasing, customers should confirm that the material is appropriate for their intended investigation and ensure that acquisition, possession, importation, and experimental use comply with applicable regulations in their jurisdiction.
Product availability, documentation, and delivery eligibility may vary by destination.
Researchers requiring additional product or batch information should review the available documentation or contact Axion Peptide Lab before ordering. ARA-290 16MG Research Peptide
ARA-290 16MG is supplied strictly as a scientific research material.
It is not intended for self-administration, human consumption, veterinary use, diagnosis, prevention, treatment, or any other therapeutic application.
The information provided here describes scientific and laboratory research contexts only and should not be interpreted as medical advice. ARA-290 16MG Research Peptide
For Research Use Only – Not for human consumption.
ARA-290 is a synthetic 11-amino-acid peptide, also known as cibinetide, supplied here in a 16MG laboratory research format.
Yes. Cibinetide is a recognised name for ARA-290. The molecule is also sometimes referred to as ARA290 and pyroglutamate helix B surface peptide.
The reported sequence is XEQLERALNSS, representing an 11-amino-acid synthetic peptide.
Scientific research has examined areas including receptor-associated signalling, cellular responses, tissue-protective pathways, inflammatory signalling, and neurological research models.
No. The Axion Peptide Lab product is supplied strictly for laboratory research and analytical investigation and is not intended for human consumption or administration.
No. It represents the quantity of research material supplied and is not a dosage recommendation.
No. Axion Peptide Lab does not provide personal dosing, administration, therapeutic, or medical-use instructions for research peptides. ARA-290 16MG Research Peptide
Researchers should follow the product-specific storage instructions supplied with their material and protect research peptides from inappropriate environmental conditions.
The product is intended for qualified researchers, laboratories, scientific institutions, analytical facilities, and other customers conducting legitimate controlled research.
ARA-290 16MG can be ordered for legitimate research purposes from AxionPeptideLab.com, subject to availability, destination eligibility, and applicable regulations.
